TGF-β1L-β3/L-β3 mice express Tgfb3 cDNA under control of the Tgfb1 LAP. These mice may be useful for studying the phenotypic differences elicited by TGF-β isoforms.
Ashok B Kulkarni, NIDCR NIH
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted | Tgfb1 | transforming growth factor, beta 1 |
TGF-β1L-β3/L-β3 mice contain an HA-tagged transforming growth factor, beta 3 (Tgfb3) cDNA, and a frt-flanked neo cassette, expressed under control of the transforming growth factor, beta 1 (Tgfb1) promoter/enhancer sequences. TGFB isoforms are important cytokines that influence cell growth, cell differentiation, apoptosis, and cellular homeostasis. Each isoform contains a latency associated peptide (LAP) domain, required for localization and activation, and a receptor binding ligand, required for cell signaling. Each LAP sequences only shares 40% sequence homology between isoforms, while the ligands share 80% homology and all contain nine conserved cysteines. All three TGF-β proteins have distinct cell-specific expression patterns that reflect the differences in the promoters located within each homologue's gene. In these TGF-β1L-β3/L-β3 mice, the TGF-β1 LAP is maintained for localization and activation but cell signaling occurs through the TGF-β3 ligand. These mice do not exhibit the embryonic lethality, vasculogenesis defects, or autoimmunity associated with TGF-β1 deficiency. These TGF-β1L-β3/L-β3 mice have a shortened lifespan and display tooth and bone mineralization defects. These mice display an improved metabolic phenotype with reduced body weight gain and enhanced glucose tolerance, by induction of beneficial changes to the white adipose tissue compartment. These mice also exhibit no defects in palate development. Homozygotes are viable and fertile, with a median survival of 30.5 weeks.
A targeting vector was designed with the transcriptional start site, and exon 1 and intron 1, of the transforming growth factor, beta 1 (Tgfb1) gene driving expression of an HA-tagged transforming growth factor, beta 3 (Tgfb3) cDNA. A loxP-flanked neomycin resistance cassette, in reverse orientation to the gene, was placed immediately downstream. This construct was electroporated into (129X1/SvJ x 129S1/Sv)F1-Kitl+-derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient C57BL/6NCrl Blastocysts and chimeric mice were bred together. These TGF-β1L-β3/L-β3 mice were maintained by sibling matings. Upon arrival at The Jackson Laboratory, mice were bred with 129S1/SvImJ inbred mice (Stock No. 002448) for at least one generation to establish the colony.
Expressed Gene | Tgfb3, transforming growth factor, beta 3, mouse, laboratory |
---|---|
Site of Expression |
Allele Name | targeted mutation 1, Ashok B Kulkarni |
---|---|
Allele Type | Targeted |
Allele Synonym(s) | TGF-beta1Lbeta3 |
Gene Symbol and Name | Tgfb1, transforming growth factor, beta 1 |
Gene Synonym(s) | |
Expressed Gene | Tgfb3, transforming growth factor, beta 3, mouse, laboratory |
Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ |
Chromosome | 7 |
Molecular Note | The HA-tagged coding sequence for Tgfb3 fused with the sequence of the endogenous gene's latency associated peptide (LAP) and followed by a floxed neomycin resistance cassette replaced exon 2. ELISA confirmed the absence of protein expression in the serum. Western blot analysis confirmed the expression of the HA-tagged protein. |
When maintaining a live colony, homozygous mice may be bred. Homozygotes are viable and fertile, with a median survival of 30.5 weeks.
When using the 129-Tgfb1tm1(Tgfb3)Kul/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #024931 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Tgfb1<tm1(Tgfb3)Kul> |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.